Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Novartis AG (NVS) – Novartis AG Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novartis (NVS) trades at $154.98, up 0.36% with a bullish technical signal from moving averages. The company shows strong profitability with 24.67% net margin and 31.01% ROE, though valuation ratios appear elevated with P/E of 21.69. Recent earnings have been mixed with Q1 2026 results pending, while strategic acquisitions like the $2 billion Excellergy deal aim to strengthen the immunology pipeline. Cash flow trends show solid operational performance with $17.62B from operations in 2024.
The outlook remains cautiously optimistic with analyst consensus leaning Hold (68%) despite recent pipeline expansion. Key risks include patent cliffs and rising debt-to-asset ratio reaching 30.26% in 2025. Revenue growth projection to $70B by 2030 provides upside potential, but investors should weigh acquisition integration success against valuation concerns.
Read full analysis

Key Stats

  • Market Cap
    $294.54B
  • Sector
    Health
  • 3M Drawdown
    -13.4%
  • Enterprise Value
    $318.38B
  • Dividend Yield
    3.06%
  • Typical Hold Time
    78 days
$154.86
52W Low: $103.4
10 Apr 2025
52W High: $168.62
27 Feb 2026

Novartis AG (NVS) is currently valued at a market capitalization of $294.54B, with an enterprise value of $318.38B. Over the past 52 weeks, Novartis AG has traded between a low of $103.4 and a high of $168.62, highlighting its annual price range. Over the past three months, Novartis AG has recorded a drawdown of -13.4%, reflecting recent price volatility. Novartis AG offers a dividend yield of 3.06%, with the most recent dividend of $4.77 paid on 11 Mar 26. On average, investors hold Novartis AG for approximately 78 days, indicating typical investor behavior on the platform.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.


Technical Indicators
|
|
|
Overall Summary
Bearish (13)Neutral (4)Bullish (10)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $294.54B
  • Sector
    Health
  • 3M Drawdown
    -13.4%
  • Enterprise Value
    $318.38B
  • Dividend Yield
    3.06%
  • Typical Hold Time
    78 days
$154.86
52W Low: $103.4
10 Apr 2025
52W High: $168.62
27 Feb 2026

Novartis AG (NVS) is currently valued at a market capitalization of $294.54B, with an enterprise value of $318.38B. Over the past 52 weeks, Novartis AG has traded between a low of $103.4 and a high of $168.62, highlighting its annual price range. Over the past three months, Novartis AG has recorded a drawdown of -13.4%, reflecting recent price volatility. Novartis AG offers a dividend yield of 3.06%, with the most recent dividend of $4.77 paid on 11 Mar 26. On average, investors hold Novartis AG for approximately 78 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!